In September, the European Medicines Agency's committee recommended against renewing the conditional marketing authorisation for Blenrep, a setback to the key oncology unit GSK has been looking to strengthen. GSK said last month that Blenrep, which was the second-largest contributor to GSK's oncology business in 2022, had reached a key goal in a separate late-stage trial.
UK s SThree said on Thursday it performed in line with market views for the year after the recruiter posted a fall in annual net fees, hurt by sluggish hiring market conditions. .
BP said it will pull back up
to 32.4 million pounds in remuneration from
former CEO Bernard Looney after the British oil giant concluded
he knowingly misled the board regarding personal.
BP said on Wednesday its
former CEO Bernard Looney will not receive further salary or
benefits after the British oil giant concluded he knowingly
misled the board and dismissed him effective Dec..
BP pulls back $40 million in pay from former CEO Looney streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.